Share Price and Basic Stock Data
Last Updated: January 2, 2026, 7:35 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kothari Sugars & Chemicals Ltd operates in the sugar industry, with its current market capitalization reported at ₹224 Cr and a share price of ₹27.0. The company has demonstrated fluctuating revenue trends over the past quarters. For instance, sales rose significantly from ₹116.81 Cr in September 2022 to ₹609 Cr for the year ending March 2023. However, the company experienced a decline in revenue to ₹503 Cr for the fiscal year ending March 2024 and is expected to further decrease to ₹310 Cr by March 2025. This trend indicates a volatile sales environment, likely influenced by market conditions and operational challenges in the sugar sector. The quarterly sales figures also reveal variability, with a peak of ₹207.48 Cr in March 2023, followed by a downturn to ₹113.18 Cr in September 2023. Such fluctuations highlight the need for the company to stabilize its revenue streams amid an unpredictable market landscape.
Profitability and Efficiency Metrics
Kothari Sugars has faced challenges in maintaining profitability, as indicated by its reported operating profit margin (OPM) of -11.70%, reflecting ongoing operational inefficiencies. The company recorded a net profit of ₹-1 Cr for the period ending September 2023, showcasing its struggle to achieve consistent profitability. The operating profit for the last fiscal year stood at ₹61 Cr, but this was accompanied by a decline to ₹44 Cr in March 2024 and an anticipated drop to ₹12 Cr in March 2025. Efficiency metrics such as return on equity (ROE) and return on capital employed (ROCE) were reported at 1.69% and 3.22%, respectively, which are notably low compared to industry benchmarks. Additionally, the cash conversion cycle (CCC) remained at 71 days, indicating potential inefficiencies in managing working capital. These profitability and efficiency metrics raise concerns over the company’s operational management and its ability to generate sustainable profits.
Balance Sheet Strength and Financial Ratios
The balance sheet of Kothari Sugars reflects a cautious financial stance, with total borrowings reported at ₹49 Cr against reserves of ₹200 Cr. The company’s debt-to-equity ratio is relatively low, indicating a conservative approach to leveraging. The interest coverage ratio (ICR) stood at 5.08x, suggesting that the company can cover its interest expenses comfortably, although this figure could be improved for greater financial stability. The price-to-book value (P/BV) ratio is notably low at 0.11x, which may suggest that the stock is undervalued compared to its book value. Furthermore, the company’s total assets were reported at ₹419 Cr, with a significant portion allocated to fixed assets. However, the declining trend in net profits and operational profitability highlights the need for a strategic reassessment of asset utilization and overall financial health. Overall, while the balance sheet reflects some strengths, the profitability concerns must be addressed to enhance financial stability.
Shareholding Pattern and Investor Confidence
Kothari Sugars has a concentrated shareholding structure, with promoters holding 73.53% of the total shares, indicating strong control by the founding family. This high promoter stake may instill confidence among investors regarding the company’s long-term vision and stability. However, foreign institutional investors (FIIs) have reduced their holdings from 0.74% in December 2022 to a mere 0.22% by September 2025, which raises concerns over external investor confidence. Domestic institutional investors (DIIs) also maintained a modest stake, hovering around 0.63%. The public shareholding has increased from 24.89% to 25.61% over the same period, suggesting a slight rise in retail investor interest. The total number of shareholders has also seen a notable increase from 46,599 in December 2022 to 68,598 by September 2025, reflecting a growing interest in the stock despite the company’s profitability challenges. This mixed sentiment underscores the importance of addressing operational issues to retain and attract investors.
Outlook, Risks, and Final Insight
The outlook for Kothari Sugars remains mixed, given its current financial performance and market position. Key strengths include a strong promoter holding, which can provide stability and strategic direction, and a conservative debt profile that allows for financial flexibility. However, significant risks persist, such as the volatility in revenue and profitability coupled with low operational efficiency. The company must enhance its operational management to improve OPM and ROCE to align more closely with industry standards. Additionally, the ongoing decline in net profit and sales raises concerns about future growth prospects. To navigate these challenges, Kothari Sugars may need to implement strategic initiatives focused on cost management and market expansion. A successful turnaround strategy could potentially restore investor confidence and improve financial performance in the long run. However, failure to address these operational issues may hinder the company’s growth trajectory and investor sentiment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 73.0 Cr. | 9.83 | 16.7/7.02 | 261 | 16.8 | 0.00 % | 36.6 % | % | 10.0 |
| Dhampure Speciality Sugars Ltd | 87.8 Cr. | 100 | 123/82.0 | 22.3 | 45.3 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 533 Cr. | 80.3 | 120/57.3 | 312 | 145 | 1.56 % | 3.97 % | 1.56 % | 10.0 |
| DCM Shriram Industries Ltd | 714 Cr. | 54.6 | 63.1/44.9 | 11.7 | 105 | 3.65 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 532 Cr. | 3.72 | 12.4/3.03 | 42.1 | 3.52 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,755.56 Cr | 260.21 | 43.46 | 225.56 | 0.76% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 116.81 | 128.28 | 207.48 | 162.96 | 113.18 | 132.31 | 94.28 | 89.62 | 101.59 | 82.75 | 36.05 | 66.69 | 68.04 |
| Expenses | 114.49 | 136.43 | 178.65 | 133.19 | 101.47 | 132.58 | 91.17 | 88.54 | 90.95 | 79.35 | 38.91 | 65.60 | 76.00 |
| Operating Profit | 2.32 | -8.15 | 28.83 | 29.77 | 11.71 | -0.27 | 3.11 | 1.08 | 10.64 | 3.40 | -2.86 | 1.09 | -7.96 |
| OPM % | 1.99% | -6.35% | 13.90% | 18.27% | 10.35% | -0.20% | 3.30% | 1.21% | 10.47% | 4.11% | -7.93% | 1.63% | -11.70% |
| Other Income | 4.18 | 2.09 | 5.61 | 2.53 | 3.61 | 4.02 | 5.24 | 3.96 | 3.56 | 9.15 | 6.07 | 5.84 | 2.25 |
| Interest | 1.31 | 0.69 | 0.34 | 1.46 | 1.06 | 0.23 | 0.79 | 2.20 | 0.82 | 0.00 | 0.56 | 1.67 | 1.46 |
| Depreciation | 3.47 | 3.50 | 3.55 | 3.34 | 3.63 | 3.54 | 3.77 | 3.66 | 3.66 | 3.67 | 3.66 | 3.62 | 3.63 |
| Profit before tax | 1.72 | -10.25 | 30.55 | 27.50 | 10.63 | -0.02 | 3.79 | -0.82 | 9.72 | 8.88 | -1.01 | 1.64 | -10.80 |
| Tax % | -55.23% | -28.49% | 22.39% | 34.87% | 51.27% | -3,850.00% | -48.81% | -35.37% | 35.70% | 39.19% | -31.68% | 23.78% | -32.96% |
| Net Profit | 2.67 | -7.33 | 23.71 | 17.90 | 5.18 | 0.76 | 5.65 | -0.53 | 6.25 | 5.40 | -0.69 | 1.25 | -7.23 |
| EPS in Rs | 0.32 | -0.88 | 2.86 | 2.16 | 0.62 | 0.09 | 0.68 | -0.06 | 0.75 | 0.65 | -0.08 | 0.15 | -0.87 |
Last Updated: December 30, 2025, 5:32 am
Below is a detailed analysis of the quarterly data for Kothari Sugars & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 68.04 Cr.. The value appears strong and on an upward trend. It has increased from 66.69 Cr. (Jun 2025) to 68.04 Cr., marking an increase of 1.35 Cr..
- For Expenses, as of Sep 2025, the value is 76.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 65.60 Cr. (Jun 2025) to 76.00 Cr., marking an increase of 10.40 Cr..
- For Operating Profit, as of Sep 2025, the value is -7.96 Cr.. The value appears to be declining and may need further review. It has decreased from 1.09 Cr. (Jun 2025) to -7.96 Cr., marking a decrease of 9.05 Cr..
- For OPM %, as of Sep 2025, the value is -11.70%. The value appears to be declining and may need further review. It has decreased from 1.63% (Jun 2025) to -11.70%, marking a decrease of 13.33%.
- For Other Income, as of Sep 2025, the value is 2.25 Cr.. The value appears to be declining and may need further review. It has decreased from 5.84 Cr. (Jun 2025) to 2.25 Cr., marking a decrease of 3.59 Cr..
- For Interest, as of Sep 2025, the value is 1.46 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.67 Cr. (Jun 2025) to 1.46 Cr., marking a decrease of 0.21 Cr..
- For Depreciation, as of Sep 2025, the value is 3.63 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.62 Cr. (Jun 2025) to 3.63 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is -10.80 Cr.. The value appears to be declining and may need further review. It has decreased from 1.64 Cr. (Jun 2025) to -10.80 Cr., marking a decrease of 12.44 Cr..
- For Tax %, as of Sep 2025, the value is -32.96%. The value appears to be improving (decreasing) as expected. It has decreased from 23.78% (Jun 2025) to -32.96%, marking a decrease of 56.74%.
- For Net Profit, as of Sep 2025, the value is -7.23 Cr.. The value appears to be declining and may need further review. It has decreased from 1.25 Cr. (Jun 2025) to -7.23 Cr., marking a decrease of 8.48 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.87. The value appears to be declining and may need further review. It has decreased from 0.15 (Jun 2025) to -0.87, marking a decrease of 1.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:05 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 323 | 340 | 247 | 317 | 287 | 332 | 352 | 419 | 422 | 609 | 503 | 310 | 254 |
| Expenses | 302 | 331 | 229 | 280 | 259 | 309 | 324 | 386 | 373 | 548 | 458 | 298 | 260 |
| Operating Profit | 21 | 9 | 18 | 36 | 28 | 23 | 28 | 33 | 50 | 61 | 44 | 12 | -6 |
| OPM % | 7% | 3% | 7% | 11% | 10% | 7% | 8% | 8% | 12% | 10% | 9% | 4% | -2% |
| Other Income | 9 | 11 | 7 | -1 | -5 | 20 | 11 | 10 | 8 | 12 | 15 | 23 | 23 |
| Interest | 10 | 5 | 7 | 8 | 6 | 7 | 7 | 5 | 4 | 4 | 4 | 4 | 4 |
| Depreciation | 16 | 16 | 15 | 15 | 14 | 13 | 13 | 14 | 14 | 14 | 14 | 15 | 15 |
| Profit before tax | 5 | -0 | 3 | 13 | 3 | 23 | 19 | 23 | 39 | 55 | 42 | 17 | -1 |
| Tax % | 39% | 1,200% | 58% | 17% | 82% | 44% | -2% | 19% | 14% | 24% | 30% | 38% | |
| Net Profit | 3 | -5 | 1 | 10 | 0 | 13 | 19 | 19 | 34 | 42 | 29 | 10 | -1 |
| EPS in Rs | 0.34 | -0.55 | 0.14 | 1.26 | 0.06 | 1.53 | 2.34 | 2.29 | 4.11 | 5.06 | 3.56 | 1.26 | -0.15 |
| Dividend Payout % | 149% | 0% | 0% | 40% | 0% | 33% | 0% | 0% | 0% | 20% | 14% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -266.67% | 120.00% | 900.00% | -100.00% | 46.15% | 0.00% | 78.95% | 23.53% | -30.95% | -65.52% |
| Change in YoY Net Profit Growth (%) | 0.00% | 386.67% | 780.00% | -1000.00% | 146.15% | -46.15% | 78.95% | -55.42% | -54.48% | -34.56% |
Kothari Sugars & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -3% |
| 3 Years: | -10% |
| TTM: | -33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -20% |
| 3 Years: | -47% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | -10% |
| 1 Year: | -43% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 9:20 am
Balance Sheet
Last Updated: December 4, 2025, 1:32 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 |
| Reserves | 38 | 34 | 35 | 49 | 56 | 69 | 84 | 103 | 137 | 175 | 196 | 206 | 200 |
| Borrowings | 144 | 166 | 175 | 146 | 120 | 116 | 84 | 36 | 57 | 38 | 70 | 50 | 49 |
| Other Liabilities | 110 | 75 | 76 | 103 | 110 | 123 | 124 | 119 | 118 | 137 | 135 | 111 | 87 |
| Total Liabilities | 375 | 358 | 368 | 380 | 370 | 391 | 375 | 341 | 395 | 433 | 483 | 451 | 419 |
| Fixed Assets | 219 | 209 | 195 | 191 | 178 | 167 | 172 | 162 | 153 | 152 | 164 | 150 | 150 |
| CWIP | 6 | 0 | 0 | 0 | -0 | 1 | -0 | 0 | 1 | 9 | 0 | 4 | 10 |
| Investments | 16 | 18 | 18 | 20 | 33 | 48 | 30 | 58 | 71 | 72 | 100 | 133 | 116 |
| Other Assets | 135 | 131 | 155 | 169 | 159 | 174 | 172 | 121 | 170 | 200 | 219 | 162 | 143 |
| Total Assets | 375 | 358 | 368 | 380 | 370 | 391 | 375 | 341 | 395 | 433 | 483 | 451 | 419 |
Below is a detailed analysis of the balance sheet data for Kothari Sugars & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 83.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 83.00 Cr..
- For Reserves, as of Sep 2025, the value is 200.00 Cr.. The value appears to be declining and may need further review. It has decreased from 206.00 Cr. (Mar 2025) to 200.00 Cr., marking a decrease of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 49.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 50.00 Cr. (Mar 2025) to 49.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 87.00 Cr.. The value appears to be improving (decreasing). It has decreased from 111.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 24.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 419.00 Cr.. The value appears to be improving (decreasing). It has decreased from 451.00 Cr. (Mar 2025) to 419.00 Cr., marking a decrease of 32.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 150.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 150.00 Cr..
- For CWIP, as of Sep 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 6.00 Cr..
- For Investments, as of Sep 2025, the value is 116.00 Cr.. The value appears to be declining and may need further review. It has decreased from 133.00 Cr. (Mar 2025) to 116.00 Cr., marking a decrease of 17.00 Cr..
- For Other Assets, as of Sep 2025, the value is 143.00 Cr.. The value appears to be declining and may need further review. It has decreased from 162.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 19.00 Cr..
- For Total Assets, as of Sep 2025, the value is 419.00 Cr.. The value appears to be declining and may need further review. It has decreased from 451.00 Cr. (Mar 2025) to 419.00 Cr., marking a decrease of 32.00 Cr..
Notably, the Reserves (200.00 Cr.) exceed the Borrowings (49.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -123.00 | -157.00 | -157.00 | -110.00 | -92.00 | -93.00 | -56.00 | -3.00 | -7.00 | 23.00 | -26.00 | -38.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 9 | 14 | 16 | 23 | 19 | 28 | 18 | 21 | 17 | 16 | 20 |
| Inventory Days | 152 | 139 | 236 | 235 | 224 | 216 | 181 | 101 | 165 | 117 | 180 | 161 |
| Days Payable | 72 | 45 | 60 | 88 | 133 | 127 | 111 | 95 | 99 | 73 | 93 | 110 |
| Cash Conversion Cycle | 95 | 103 | 189 | 162 | 114 | 108 | 99 | 24 | 88 | 61 | 103 | 71 |
| Working Capital Days | 30 | 20 | 8 | 0 | -17 | -10 | -1 | 2 | 16 | 24 | 30 | 36 |
| ROCE % | 5% | 1% | 3% | 9% | 7% | 10% | 8% | 10% | 17% | 18% | 14% | 3% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.28 | 1.44 | 0.37 | -0.26 | 0.43 |
| Diluted EPS (Rs.) | 0.28 | 1.44 | 0.37 | -0.26 | 0.43 |
| Cash EPS (Rs.) | 1.71 | 3.06 | 1.91 | 1.39 | 2.18 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 16.85 | 17.41 | 15.66 | 15.52 | 16.06 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 16.85 | 17.41 | 15.66 | 15.52 | 16.06 |
| Revenue From Operations / Share (Rs.) | 34.62 | 38.21 | 29.75 | 41.02 | 39.02 |
| PBDIT / Share (Rs.) | 3.98 | 5.05 | 2.97 | 2.52 | 3.64 |
| PBIT / Share (Rs.) | 2.31 | 3.29 | 1.20 | 0.59 | 1.70 |
| PBT / Share (Rs.) | 0.30 | 1.56 | 0.34 | -0.02 | 0.49 |
| Net Profit / Share (Rs.) | 0.04 | 1.30 | 0.13 | -0.53 | 0.23 |
| NP After MI And SOA / Share (Rs.) | 0.27 | 1.44 | 0.36 | -0.26 | 0.43 |
| PBDIT Margin (%) | 11.50 | 13.22 | 9.97 | 6.14 | 9.32 |
| PBIT Margin (%) | 6.67 | 8.60 | 4.03 | 1.44 | 4.35 |
| PBT Margin (%) | 0.86 | 4.08 | 1.16 | -0.05 | 1.27 |
| Net Profit Margin (%) | 0.11 | 3.39 | 0.46 | -1.31 | 0.61 |
| NP After MI And SOA Margin (%) | 0.79 | 3.77 | 1.23 | -0.63 | 1.11 |
| Return on Networth / Equity (%) | 1.64 | 8.28 | 2.33 | -1.68 | 2.70 |
| Return on Capital Employeed (%) | 9.11 | 11.54 | 3.90 | 1.80 | 4.85 |
| Return On Assets (%) | 0.60 | 2.98 | 0.79 | -0.58 | 0.92 |
| Long Term Debt / Equity (X) | 0.25 | 0.37 | 0.71 | 0.83 | 0.86 |
| Total Debt / Equity (X) | 0.73 | 0.78 | 1.06 | 1.16 | 0.89 |
| Asset Turnover Ratio (%) | 0.73 | 0.82 | 0.66 | 0.91 | 0.83 |
| Current Ratio (X) | 1.07 | 1.14 | 1.33 | 1.46 | 1.46 |
| Quick Ratio (X) | 0.29 | 0.26 | 0.40 | 0.45 | 0.40 |
| Inventory Turnover Ratio (X) | 1.47 | 1.92 | 1.83 | 2.58 | 2.51 |
| Dividend Payout Ratio (NP) (%) | 217.73 | 0.00 | 0.00 | 0.00 | 115.05 |
| Dividend Payout Ratio (CP) (%) | 30.89 | 0.00 | 0.00 | 0.00 | 21.03 |
| Earning Retention Ratio (%) | -117.73 | 0.00 | 0.00 | 0.00 | -15.05 |
| Cash Earning Retention Ratio (%) | 69.11 | 0.00 | 0.00 | 0.00 | 78.97 |
| Interest Coverage Ratio (X) | 5.08 | 5.16 | 3.47 | 4.11 | 3.03 |
| Interest Coverage Ratio (Post Tax) (X) | 2.62 | 3.09 | 1.16 | 0.12 | 1.20 |
| Enterprise Value (Cr.) | 116.17 | 126.76 | 138.08 | 160.99 | 139.15 |
| EV / Net Operating Revenue (X) | 0.40 | 0.40 | 0.55 | 0.47 | 0.43 |
| EV / EBITDA (X) | 3.52 | 3.03 | 5.61 | 7.71 | 4.61 |
| MarketCap / Net Operating Revenue (X) | 0.05 | 0.05 | 0.06 | 0.04 | 0.05 |
| Retention Ratios (%) | -117.73 | 0.00 | 0.00 | 0.00 | -15.05 |
| Price / BV (X) | 0.11 | 0.11 | 0.12 | 0.12 | 0.12 |
| Price / Net Operating Revenue (X) | 0.05 | 0.05 | 0.06 | 0.04 | 0.05 |
| EarningsYield | 0.13 | 0.72 | 0.18 | -0.13 | 0.21 |
After reviewing the key financial ratios for Kothari Sugars & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 18, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 17) to 0.28, marking a decrease of 1.16.
- For Diluted EPS (Rs.), as of Mar 18, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 1.44 (Mar 17) to 0.28, marking a decrease of 1.16.
- For Cash EPS (Rs.), as of Mar 18, the value is 1.71. This value is below the healthy minimum of 3. It has decreased from 3.06 (Mar 17) to 1.71, marking a decrease of 1.35.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.85. It has decreased from 17.41 (Mar 17) to 16.85, marking a decrease of 0.56.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 16.85. It has decreased from 17.41 (Mar 17) to 16.85, marking a decrease of 0.56.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 34.62. It has decreased from 38.21 (Mar 17) to 34.62, marking a decrease of 3.59.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 3.98. This value is within the healthy range. It has decreased from 5.05 (Mar 17) to 3.98, marking a decrease of 1.07.
- For PBIT / Share (Rs.), as of Mar 18, the value is 2.31. This value is within the healthy range. It has decreased from 3.29 (Mar 17) to 2.31, marking a decrease of 0.98.
- For PBT / Share (Rs.), as of Mar 18, the value is 0.30. This value is within the healthy range. It has decreased from 1.56 (Mar 17) to 0.30, marking a decrease of 1.26.
- For Net Profit / Share (Rs.), as of Mar 18, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 1.30 (Mar 17) to 0.04, marking a decrease of 1.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is 0.27. This value is below the healthy minimum of 2. It has decreased from 1.44 (Mar 17) to 0.27, marking a decrease of 1.17.
- For PBDIT Margin (%), as of Mar 18, the value is 11.50. This value is within the healthy range. It has decreased from 13.22 (Mar 17) to 11.50, marking a decrease of 1.72.
- For PBIT Margin (%), as of Mar 18, the value is 6.67. This value is below the healthy minimum of 10. It has decreased from 8.60 (Mar 17) to 6.67, marking a decrease of 1.93.
- For PBT Margin (%), as of Mar 18, the value is 0.86. This value is below the healthy minimum of 10. It has decreased from 4.08 (Mar 17) to 0.86, marking a decrease of 3.22.
- For Net Profit Margin (%), as of Mar 18, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 3.39 (Mar 17) to 0.11, marking a decrease of 3.28.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is 0.79. This value is below the healthy minimum of 8. It has decreased from 3.77 (Mar 17) to 0.79, marking a decrease of 2.98.
- For Return on Networth / Equity (%), as of Mar 18, the value is 1.64. This value is below the healthy minimum of 15. It has decreased from 8.28 (Mar 17) to 1.64, marking a decrease of 6.64.
- For Return on Capital Employeed (%), as of Mar 18, the value is 9.11. This value is below the healthy minimum of 10. It has decreased from 11.54 (Mar 17) to 9.11, marking a decrease of 2.43.
- For Return On Assets (%), as of Mar 18, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 2.98 (Mar 17) to 0.60, marking a decrease of 2.38.
- For Long Term Debt / Equity (X), as of Mar 18, the value is 0.25. This value is within the healthy range. It has decreased from 0.37 (Mar 17) to 0.25, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 18, the value is 0.73. This value is within the healthy range. It has decreased from 0.78 (Mar 17) to 0.73, marking a decrease of 0.05.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 0.73. It has decreased from 0.82 (Mar 17) to 0.73, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 18, the value is 1.07. This value is below the healthy minimum of 1.5. It has decreased from 1.14 (Mar 17) to 1.07, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 18, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 17) to 0.29, marking an increase of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 18, the value is 1.47. This value is below the healthy minimum of 4. It has decreased from 1.92 (Mar 17) to 1.47, marking a decrease of 0.45.
- For Dividend Payout Ratio (NP) (%), as of Mar 18, the value is 217.73. This value exceeds the healthy maximum of 50. It has increased from 0.00 (Mar 17) to 217.73, marking an increase of 217.73.
- For Dividend Payout Ratio (CP) (%), as of Mar 18, the value is 30.89. This value is within the healthy range. It has increased from 0.00 (Mar 17) to 30.89, marking an increase of 30.89.
- For Earning Retention Ratio (%), as of Mar 18, the value is -117.73. This value is below the healthy minimum of 40. It has decreased from 0.00 (Mar 17) to -117.73, marking a decrease of 117.73.
- For Cash Earning Retention Ratio (%), as of Mar 18, the value is 69.11. This value is within the healthy range. It has increased from 0.00 (Mar 17) to 69.11, marking an increase of 69.11.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 5.08. This value is within the healthy range. It has decreased from 5.16 (Mar 17) to 5.08, marking a decrease of 0.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 2.62. This value is below the healthy minimum of 3. It has decreased from 3.09 (Mar 17) to 2.62, marking a decrease of 0.47.
- For Enterprise Value (Cr.), as of Mar 18, the value is 116.17. It has decreased from 126.76 (Mar 17) to 116.17, marking a decrease of 10.59.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 0.40. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.40.
- For EV / EBITDA (X), as of Mar 18, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 3.03 (Mar 17) to 3.52, marking an increase of 0.49.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.05.
- For Retention Ratios (%), as of Mar 18, the value is -117.73. This value is below the healthy minimum of 30. It has decreased from 0.00 (Mar 17) to -117.73, marking a decrease of 117.73.
- For Price / BV (X), as of Mar 18, the value is 0.11. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.11.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 17) which recorded 0.05.
- For EarningsYield, as of Mar 18, the value is 0.13. This value is below the healthy minimum of 5. It has decreased from 0.72 (Mar 17) to 0.13, marking a decrease of 0.59.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kothari Sugars & Chemicals Ltd:
- Net Profit Margin: 0.11%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.11% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.64% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.29
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 43.46)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.73
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.11%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | Kothari Buildings, No.115, Mahatma Gandhi Salai, Chennai (Madras) Tamil Nadu 600034 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Nina B Kothari | Chairperson |
| Mr. Arjun B Kothari | Managing Director |
| Mr. M Silvester Goldwin | Whole Time Director |
| Mr. C V Krishnan | Independent Director |
| Mr. M R Mohan | Independent Director |
| Mr. S Sundarraman | Independent Director |
FAQ
What is the intrinsic value of Kothari Sugars & Chemicals Ltd?
Kothari Sugars & Chemicals Ltd's intrinsic value (as of 02 January 2026) is ₹7.07 which is 73.91% lower the current market price of ₹27.10, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹224 Cr. market cap, FY2025-2026 high/low of ₹46.7/26.0, reserves of ₹200 Cr, and liabilities of ₹419 Cr.
What is the Market Cap of Kothari Sugars & Chemicals Ltd?
The Market Cap of Kothari Sugars & Chemicals Ltd is 224 Cr..
What is the current Stock Price of Kothari Sugars & Chemicals Ltd as on 02 January 2026?
The current stock price of Kothari Sugars & Chemicals Ltd as on 02 January 2026 is ₹27.1.
What is the High / Low of Kothari Sugars & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kothari Sugars & Chemicals Ltd stocks is ₹46.7/26.0.
What is the Stock P/E of Kothari Sugars & Chemicals Ltd?
The Stock P/E of Kothari Sugars & Chemicals Ltd is .
What is the Book Value of Kothari Sugars & Chemicals Ltd?
The Book Value of Kothari Sugars & Chemicals Ltd is 34.2.
What is the Dividend Yield of Kothari Sugars & Chemicals Ltd?
The Dividend Yield of Kothari Sugars & Chemicals Ltd is 0.00 %.
What is the ROCE of Kothari Sugars & Chemicals Ltd?
The ROCE of Kothari Sugars & Chemicals Ltd is 3.22 %.
What is the ROE of Kothari Sugars & Chemicals Ltd?
The ROE of Kothari Sugars & Chemicals Ltd is 1.69 %.
What is the Face Value of Kothari Sugars & Chemicals Ltd?
The Face Value of Kothari Sugars & Chemicals Ltd is 10.0.